Sana Biotechnology Inc (NASDAQ: SANA) has obtained non-exclusive commercial rights to a clinically validated fully-human BCMA CAR construct from IASO Biotherapeutics and Innovent Biologics.

  • The constructs can be used in certain in vivo gene therapy and ex vivo hypoimmune cell therapy applications. 
  • IASO Bio and Innovent will receive an upfront payment and are entitled to receive up to approximately $204 million in potential development and regulatory milestone payments across up to six products, as well as royalties.
  • Related: Sana Obtains License To Beam Therapeutics’ CRISPR Cas12b Gene Editing Technology.
  • B cell maturation antigen (BCMA) has been validated as a target for autologous CAR T therapy in relapsed and/or refractory multiple myeloma.
  • Separately, Sana Biotechnology has entered into an agreement with the National Cancer Institution (NCI) for worldwide exclusive commercial rights to the NIH’s CD22 chimeric antigen receptor (CAR) with a fully-human binder for use in certain in vivo

The FDA has notified Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) that it may proceed with Phase 3 trial of its lead candidate, brilaroxazine, a serotonin and dopamine receptor modulator for schizophrenia.

  • The FDA has also signed off an additional Phase 3 trial focused on the long-term safety of brilaroxazine in patients with schizophrenia. 
  • Related: Reviva Pharma Stock Trading Higher On Detailed Positive Schizophrenia Study Results.
  • Both Phase 3 trials will be initiated simultaneously by the end of January 2022.
  • Price Action: RVPH shares are up 16.2% at $3.45 during the premarket session on the last check Monday.

Source link

EV stocks ended mixed in the week ending Jan. 7, with market leader Tesla, Inc. (NASDAQ: TSLA) giving back the strong gains notched in reaction to its stellar fourth-quarter deliveries. Stocks in the space also came under pressure along with the tech sector in the wake of hawkish commentary from the Federal Reserve this week.

Here are the key events that happened in the EV space during the week:

Tesla Achieves Record Q4 Deliveries, FSD Price Hike, Cathie Continues to Sell And More: Tesla, last Sunday, reported record deliveries of 308,600 vehicles in the fourth quarter, pushing annual deliveries to 936,172 units. The results outperformed expectations by a huge margin.

CEO Elon Musk announced through Twitter, Tesla’s full self-driving software will become more costly, rising to $12,000 beginning Jan. 17. He also said the monthly subscription price will go up when FSD is more widely released.

Cathie Wood’s Ark Invest

The battle for consumers’ attention continues with traditional television and streaming platforms competing for the most minutes watched in 2022.

What Happened: IMDb, a movie and television show database owned by Amazon.com, Inc. (NASDAQ: AMZN), shared the most anticipated new television series for 2022. The results are based on page views for the series from more than 200 million monthly visitors.

Here is a look at the 10 most anticipated new shows for 2022 and what it could mean for some publicly traded companies.

1. House of the Dragon: A “Game of Thrones” prequel called “House of the Dragon” ranks as the most searched 2022 new show on IMDB. The show’s first season of 10 episodes doesn’t have a release date but will air on HBO and HBO Max, which could boost the profile for parent company AT&T Inc. (NYSE: T) in 2022. A teaser trailer released in October has

Ethereum (CRYPTO: ETH) developers have shrugged off a warning from analysts at JPMorgan that scaling up for the network may come too late to ward off competition from rival projects.

What Happened: Ethereum developer Tim Beiko called JPMorgan’s note on the second-largest coin’s sharding efforts as “lazy/very high level critique,” as per a Decrypt report.

Pointing to an in-place mechanism that allows transactions to be executed off-chain, Beiko said, “Rollups are live today, and sharding will lower their costs, but the tech works and is now massively derisked.”

The Graph (GRT) co-founder Tegan Kline said Ethereum was the most widely used chain on the Ethereum indexing protocol.

“Of the 26 networks that The Graph supports, 66.7% of the queries are on Ethereum” said Kline.

Kline pointed to chain security being important and said “for the foreseeable future Ethereum has the most security,” reported Decrypt.

See Also: How To Buy Ethereum

 

Helen Of Troy (NASDAQ:HELE) reported its Q3 earnings results on Thursday, January 6, 2022 at 06:45 AM.

Here’s what investors need to know about the announcement.

Earnings

Helen Of Troy beat estimated earnings by 19.61%, reporting an EPS of $3.72 versus an estimate of $3.11, which surprised analysts.

Revenue was up $12.85 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.48, which was followed by a 1.94% drop in the share price the next day.

Here’s a look at Helen Of Troy’s past performance:

 

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate 2.17 2.62 1.50 3.02
EPS Actual 2.65 3.48 1.57 3.76
Revenue Estimate 428.16M 438.90M 494.74M 551.85M
Revenue Actual 475.23M 541.22M 509.38M 637.74M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga’s automated content engine and reviewed